GLP1R and obesity due to melanocortin 4 receptor deficiency: In recent weeks, sections of the press, social media, and celebrities have been gushing in their praise of a new class of drugs for the treatment of obesity (known as Glucagon Like Peptide-1 Receptor Agonist [GLP-1 RA] eg, Semaglutide with the brand name Wegovy).